Manidipine dihydrochloride

For research use only. Not for therapeutic Use.

  • CAT Number: I005342
  • CAS Number: 89226-75-5
  • Molecular Formula: C35H40Cl2N4O6
  • Molecular Weight: 683.62
  • Purity: ≥95%
Inquiry Now

Manidipine dihydrochloride (CAT: I005342), also known as Manidipine 2HCl or CV-4093, is a dihydropyridine compound that serves as a potent calcium channel blocker. Its pharmacological action involves inhibiting Ca2+ currents with an impressive IC50 value of 2.6 nM. By blocking calcium channels, Manidipine dihydrochloride reduces the influx of calcium ions into cells, leading to vasodilation and a decrease in blood pressure. This compound’s role as a calcium channel blocker highlights its significance in cardiovascular medicine, where it offers potential therapeutic applications in the management of hypertension and other cardiovascular conditions.


Catalog Number I005342
CAS Number 89226-75-5
Synonyms

5-O-[2-(4-benzhydrylpiperazin-1-yl)ethyl] 3-O-methyl 2,6-dimethyl-4-(3-nitrophenyl)-1,4-dihydropyridine-3,5-dicarboxylate;dihydrochloride

Molecular Formula C35H40Cl2N4O6
Purity ≥95%
Target Calcium Channel
Solubility DMSO 20 mg/mL
Storage 3 years -20C powder
IC50 2.6 nM
Reference

<p style=/line-height:25px/>
<br>[1]. Buset Ríos N, Rodríguez Esparragón F, Fernández-Andrade Rodríguez C, et al. Vascular and metabolic properties of manidipine . Nefrologia. 2011;31(3):268-74.
<br>[2]. Costa S, Zimetti F, Pedrelli M, et al. Manidipine reduces pro-inflammatory cytokines secretion in human endothelial cells and macrophages. Pharmacol Res. 2010 Sep;62(3):265-70.
<br>[3]. Cavalieri L, Cremonesi G. Metabolic effects of manidipine. Am J Cardiovasc Drugs. 2009;9(3):163-76. doi: 10.2165/00129784-200909030-00004.
<br>[4]. Roca-Cusachs A, Triposkiadis F. Antihypertensive effect of manidipine. Drugs. 2005;65 Suppl 2:11-9.
<br>[5]. Nagaoka A. Pharmacologic characteristics of a new calcium antagonist, manidipine: beneficial effects on renal circulation and vascular changes. Am Heart J. 1993 Feb;125(2 Pt 2):560-5.
</p>

Request a Quote